These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9829494)

  • 21. Endothelin-mediated effect of erythropoietin on blood pressure and renal hemodynamics in hypertensive rats.
    Tojo A; Doumoto M; Oka K; Numabe A; Kimura K; Yagi S
    Am J Physiol; 1996 Apr; 270(4 Pt 2):R744-8. PubMed ID: 8967402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapy.
    Lebel M; Grose JH; Kingma I; Langlois S
    Clin Exp Hypertens; 1994 Sep; 16(5):565-75. PubMed ID: 7951163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy.
    Caravaca F; López-Minguez JR; Arrobas M; Cubero J; Pizarro JL; Cid MC; Sanchez-Casado E; Miranda MP
    Nephrol Dial Transplant; 1995; 10(9):1720-4. PubMed ID: 8559495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients.
    Albitar S; Genin R; Fen-Chong M; Serveaux MO; Bourgeon B
    Nephrol Dial Transplant; 1998 May; 13(5):1206-10. PubMed ID: 9623555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells.
    Nagai T; Akizawa T; Nakashima Y; Kohjiro S; Nabeshima K; Kanamori N; Takayama K; Kinugasa E; Koshikawa S
    Nephrol Dial Transplant; 1995 Oct; 10(10):1814-9. PubMed ID: 8592587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.
    Weber C; Schmitt R; Birnboeck H; Hopfgartner G; van Marle SP; Peeters PA; Jonkman JH; Jones CR
    Clin Pharmacol Ther; 1996 Aug; 60(2):124-37. PubMed ID: 8823230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
    Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
    Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin.
    Takahashi K; Totsune K; Imai Y; Sone M; Nozuki M; Murakami O; Sekino H; Mouri T
    Clin Sci (Lond); 1993 Jan; 84(1):47-50. PubMed ID: 8382133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of convertase-related processing of proendothelin-1.
    Denault JB; D'Orléans-Juste P; Masaki T; Leduc R
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S47-50. PubMed ID: 8587448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
    Le Monnier de Gouville AC; Cavero I
    Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Martins Prata M; Teixeira de Sousa F; Barbas J; Vinhaś J; Marques da Costa A
    Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum erythropoietin levels in hemodialysed patients after administration of recombinant human erythropoietin.
    Pavlović-Kentera V; Clemons GK; Biljanović-Paunović L; Marisavljević D; Lezaić V; Pokrajac M; Djukanović L
    Biomed Pharmacother; 1992; 46(1):37-43. PubMed ID: 1421034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients.
    Hsu SP; Peng YS; Pai MF; Hung KY; Tsai TJ
    Blood Purif; 2003; 21(3):220-4. PubMed ID: 12784047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma.
    Papassotiriou J; Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2006 Jun; 52(6):1144-51. PubMed ID: 16627560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysis.
    Miyauchi T; Suzuki N; Kurihara T; Yamaguchi I; Sugishita Y; Matsumoto H; Goto K; Masaki T
    Biochem Biophys Res Commun; 1991 Jul; 178(1):276-81. PubMed ID: 2069568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion of proendothelin-1 into endothelin-1 by aspartylproteases.
    Savage P; Shetty SS; Martin LL; Jeng AY
    Int J Pept Protein Res; 1993 Sep; 42(3):227-32. PubMed ID: 8225777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption.
    Maeder MT; Brutsche MH; Staub D; Morgenthaler NG; Bergmann A; Noveanu M; Laule K; Breidthardt T; Christ A; Klima T; Reichlin T; Potocki M; Mueller C
    J Intern Med; 2009 May; 265(5):604-15. PubMed ID: 19226375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M
    Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human erythropoietin stimulates angiogenesis in vitro.
    Carlini RG; Reyes AA; Rothstein M
    Kidney Int; 1995 Mar; 47(3):740-5. PubMed ID: 7752572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.